State of Wisconsin Investment Board’s C4 Therapeutics CCCC Stock Holding History

State of Wisconsin Investment Board’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,200	Closed	-$56.2K	–	2401
2023 Q3	$56.2K	Sell	30,200 -141,400	-82%	-$431K	﹤0.01%	2418
2023 Q2	$472K	Buy	171,600 +31,168	+22%	+$100K	﹤0.01%	1849
2023 Q1	$441K	Buy	140,432 +5,758	+4%	+$33.9K	﹤0.01%	1925
2022 Q4	$795K	Buy	134,674 +23,118	+21%	+$192K	﹤0.01%	1630
2022 Q3	$978K	Buy	111,556 +5,627	+5%	+$58.4K	﹤0.01%	1554
2022 Q2	$799K	Buy	105,929 +61,429	+138%	+$541K	﹤0.01%	1792
2022 Q1	$1.08M	Hold	44,500	–	–	﹤0.01%	1628
2021 Q4	$1.43M	Hold	44,500	–	–	﹤0.01%	1351
2021 Q3	$1.99M	Hold	44,500	–	–	﹤0.01%	1284
2021 Q2	$1.68M	Buy	+44,500	New	+$1.59M	﹤0.01%	1327

Other funds holding CCCC

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State of Wisconsin Investment Board's CCCC Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of C4 Therapeutics (CCCC) in Q4 2023, closing a stake of 30,200 shares — an estimated $56.2K sold.

State of Wisconsin Investment Board first reported a position in CCCC in Q2 2021 and held it in 10 quarters. The position peaked at $1.99M in Q3 2021. 92 funds tracked by Wall St. Rank hold CCCC as of Q4 2023.

State of Wisconsin Investment Board reported no remaining C4 Therapeutics position as of Q4 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 30,200 C4 Therapeutics shares in Q4 2023, an estimated $56.2K.
State of Wisconsin Investment Board first reported a position in C4 Therapeutics in Q2 2021 and held it in 10 quarters.
State of Wisconsin Investment Board's C4 Therapeutics position peaked at $1.99M in Q3 2021.
92 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.